Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06875167
What this trial is testing

Semi-closed Loop Automated Insulin Therapy in the Pediatric Population Aged 2-6 Years With Type 1 Diabetes: Impact on Quality of Life and Glycemic Control

Who this might be right for
Type 1 DiabetesClosed LoopInsulin+2 more
Fondation Lenval 20
Not applicableLooking for participantsNCT07509671
What this trial is testing

The Treatment of Painful Diabetic Neuropathy With Diet

Who this might be right for
Painful Diabetic Neuropathy (PDN)Peripheral Neuropathy With Type 2 DiabetesVegan Diet
AdventHealth 40
Large-scale testing (Phase 3)Study completedNCT02752828
What this trial is testing

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Insulin Glargine Alone on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 521
Not applicableStudy completedNCT03263728
What this trial is testing

Cardiac Magnetic Resonance for Asymptomatic Type 2 Diabetics With Cardiovascular High Risk (CATCH) - Pilot Study

Who this might be right for
Diabetes Mellitus, Type 2Coronary Artery Disease
The University of Hong Kong 63
Not applicableStudy completedNCT00649909
What this trial is testing

Effect of Glucose Control on the Response to Aspirin in Type 2 Diabetic Patients

Who this might be right for
Diabetes Mellitus, Type II
Hadassah Medical Organization 18
Large-scale testing (Phase 3)Study completedNCT02540993
What this trial is testing

Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease

Who this might be right for
Chronic Kidney Disease
Bayer 5,734
Post-approval studies (Phase 4)Study completedNCT00658463
What this trial is testing

Effects of Rosuvastatin on the, in Vivo, Kinetic of apoB and apoA1, Using Stable Isotopes, in Type 2 Diabetic Patients

Who this might be right for
Diabetes
Centre Hospitalier Universitaire Dijon 8
Not applicableStudy completedNCT05279911
What this trial is testing

Effect of Low-level Laser Therapy on Type II Controlled Diabetic Patients After Dental Implant Insertion

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)Low-level Laser TherapyBone Density Increased
Sinai University 40
Not applicableStudy completedNCT01318564
What this trial is testing

Diabetic Treatment Adherence

Who this might be right for
Endocrine System Diseases
M.D. Anderson Cancer Center 28
Not applicableStudy completedNCT00486187
What this trial is testing

Effects of ROSIglitazone on Inflammatory Markers and Adipokines in Diabetic Patients Using an Angiotensin Receptor Blocker (TELmisartan) - The ROSITEL Study

Who this might be right for
Type 2 Diabetes Mellitus
Dr. Milan Gupta 103
Testing effectiveness (Phase 2)Study completedNCT00406458
What this trial is testing

Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diabetic Polyneuropathy
Sangamo Therapeutics 110
Large-scale testing (Phase 3)UnknownNCT05310916
What this trial is testing

Effect of SGLT2i on Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients

Who this might be right for
Diabetic Retinopathy
Nidae Alaa 60
Testing effectiveness (Phase 2)Study completedNCT03412006
What this trial is testing

Study to Investigate Efficacy, Safety and Tolerability of BAY1142524 in Patients With Type II Diabetes and a Clinical Diagnosis of Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney Disease
Bayer 152
Large-scale testing (Phase 3)WithdrawnNCT03508739
What this trial is testing

Glucagon-like Peptide-1 Metabolism and Acute Neprilysin Inhibition

Who this might be right for
Diabetes Mellitus, Type 2Pre-diabeticHypertension+1 more
University of Pennsylvania
Not applicableUnknownNCT05845190
What this trial is testing

Effect of Aerobic Training Versus Resistance Training on Plasma Homocystiene in Diabetic Patients

Who this might be right for
Diabete Type 2
Egyptian Chinese University 60
Post-approval studies (Phase 4)Ended earlyNCT02015910
What this trial is testing

Januvia (Sitagliptin) in Healing Chronic Diabetic Foot Ulcers

Who this might be right for
Type II Diabetes
Georgetown University 1
Post-approval studies (Phase 4)Study completedNCT00522470
What this trial is testing

Effects of Rosiglitazone on Serum Ghrelin and Peptide YY Levels

Who this might be right for
Type 2 Diabetes MellitusObesity
Baskent University
Not applicableStudy completedNCT01163591
What this trial is testing

To Assess the Accuracy of the eZscan Study in the Screening for Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy
Chinese University of Hong Kong 100
Post-approval studies (Phase 4)Study completedNCT01776788
What this trial is testing

Effect of Short-Term Intensive Insulin Sequential Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients

Who this might be right for
Diabetes Mellitus, Type 2
The First Affiliated Hospital of Xiamen University 156
Not applicableStudy completedNCT00970723
What this trial is testing

High Blood Pressure and Sleep Apnea in Diabetic Macular Edema

Who this might be right for
Diabetic Retinopathy
Assistance Publique - Hôpitaux de Paris 86
Next Page